BioWorld

Feb. 17, 2004

Incyte, Invitrogen Raise Funds Via Notes To Pay Down Debt

Two more companies placed convertible notes with the same goal in mind: pay off old debt with new debt, but under better terms. (BioWorld Today) Read More

Connetics Private Placement Raises $60.8M For Soriatane

Keryx Has Agreements For $32M To Support KRX-101, KRX-0401

ImClone's Wild Stock Ride, History, Fire Up Rumor Mill

Holiday Notice

BioWorld Today's offices were closed Monday, Feb. 16, in observance of President's Day in the U.S. and no issue was published that day. Read More

Zyomyx's Private Round Raises $10M For Manufacturing, Sales

Avant Raises $25M, Pushes Cash Position To Two Years

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...